Phone: 959-333-0983
Phone: 959-333-0983
$89.99
This item has been third-party tested by accredited U.S. laboratories and confirmed to meet a minimum purity of 98% through rigorous verification standards.
CJC-1295 DAC is a synthetic growth hormone–releasing hormone (GHRH) analog studied in controlled research environments for its extended half-life and sustained receptor signaling behavior.
The inclusion of a drug affinity complex (DAC) allows researchers to examine prolonged growth hormone stimulation models compared to native GHRH peptides. This compound is intended solely for laboratory and analytical research use.
$89.99
Synthetic Growth Hormone–Releasing Hormone (GHRH) Analog with Drug Affinity Complex
CJC-1295 DAC is a synthetic peptide supplied exclusively for laboratory and analytical research purposes. This compound is studied in controlled research environments for its interaction with growth hormone–releasing hormone (GHRH) receptors and its role in endocrine signaling pathway research models.
Each batch of CJC-1295 DAC is independently third-party tested to verify identity and purity, supporting accuracy and reproducibility in scientific research applications.
Growth hormone–releasing hormone (GHRH) plays a central role in regulating endogenous growth hormone secretion through receptor-mediated signaling pathways. Native GHRH peptides, however, are subject to rapid enzymatic degradation, which limits their persistence in experimental systems.
As a result, synthetic GHRH analogs have been developed to explore:
CJC-1295 DAC represents one such analog, incorporating structural modifications intended to address these limitations.
Related research concepts:
In laboratory and clinical research models, CJC-1295 DAC interacts with the GHRH receptor, initiating downstream signaling pathways associated with growth hormone regulation.
Unlike short-acting GHRH peptides, the DAC modification supports prolonged receptor engagement, allowing researchers to evaluate signaling dynamics over extended observational periods.
Importantly, published studies have demonstrated that pulsatile hormone secretion patterns may persist despite continuous stimulation by long-acting GHRH analogs, making compounds such as CJC-1295 DAC useful for investigating regulatory feedback mechanisms.
CJC-1295 DAC supplied by ResearchChemical.com is produced under controlled peptide synthesis conditions to support compound integrity, purity, and reproducibility.
Manufacturing and verification standards include:
These measures ensure transparency and reliability for laboratory research use.
CJC-1295 DAC has been investigated across a range of experimental contexts, including:
Researchers have also explored its relevance in studies examining growth hormone and insulin-like growth factor (IGF-1) axis behavior under controlled conditions.
These investigations contribute to a broader understanding of peptide-based signaling modulation and long-acting analog development.
Research Chemical products are third-party tested by MZ Biolabs, an independent laboratory based in Arizona. Each batch is analyzed to verify identity, purity, and compliance with stated specifications.
By purchasing from ResearchChemical.com, you acknowledge that you are acquiring research chemicals intended solely for scientific investigation.
These products are:
ResearchChemical.com, its manufacturers, and distributors assume no liability for misuse, improper handling, or use outside of controlled laboratory settings. It is the purchaser’s responsibility to comply with all applicable laws and regulations.
CJC-1295 DAC is studied in laboratory settings to evaluate prolonged GHRH receptor interaction and peptide stability.
No. This compound is supplied strictly for research purposes.
DAC modifications are designed to increase peptide resistance to enzymatic degradation, allowing extended study windows in controlled models.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Research Chemical products are third-party tested by MZ Biolabs, an independent laboratory based in Arizona. Each batch is analyzed to verify identity, purity, and compliance with stated specifications.
By purchasing from ResearchChemical.com, you acknowledge that you are acquiring research chemicals intended solely for scientific investigation.
These products are:
ResearchChemical.com, its manufacturers, and distributors assume no liability for misuse, improper handling, or use outside of controlled laboratory settings. It is the purchaser’s responsibility to comply with all applicable laws and regulations.
2. Teichman, S. L., Neale, A., Lawrence, B., Gagnon, C., Castaigne, J. P., & Frohman, L. A. (2006). Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults. The Journal of Clinical Endocrinology & Metabolism, 91(3), 799-805.
3. Sackmann-Sala, L., Ding, J., Frohman, L. A., & Kopchick, J. J. (2009). Activation of the GH/IGF-1 axis by CJC-1295, a long-acting GHRH analog, results in serum protein profile changes in normal adult subjects. Growth Hormone & IGF Research, 19(6), 471-477.
4. Ionescu, M., & Frohman, L. A. (2006). Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog. The Journal of Clinical Endocrinology & Metabolism, 91(12), 4792-4797.
5. Pinyot, A., Nikolovski, Z., Bosch, J., Such-Sanmartín, G., Kageyama, S., Segura, J., & Gutiérrez-Gallego, R. (2012). Growth hormone secretagogues: out of competition.Analytical and bioanalytical chemistry, 402, 1101-1108.
6. Campbell, R. M., Bongers, J., & Felix, A. M. (1995). Rational design, synthesis, and biological evaluation of novel growth hormone releasing factor analogues. Biopolymers: Original Research on Biomolecules, 37(2), 67-88.
7. Campbell, R. M., Stricker, P., Miller, R., Bongers, J., Liu, W., Lambros, T., … & Heimer, E. P. (1994). Enhanced stability and potency of novel growth hormone-releasing factor (GRF) analogues derived from rodent and human GRF sequences. Peptides, 15(3), 489-495.
8. Teichman SL, et al. Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults. The Journal of Clinical Endocrinology & Metabolism. 2006;91(3):799-805. doi: 10.1210/jc.2005-1536.
9. Ionescu, M., & Frohman, L. A. (2006). Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog. The Journal of Clinical Endocrinology & Metabolism, 91(12), 4792-4797.
10. Ma, X., Lin, L., Yue, J., Pradhan, G., Qin, G., Minze, L. J., … & Sun, Y. (2013). Ghrelin receptor regulates HFCS-induced adipose inflammation and insulin resistance. Nutrition & diabetes, 3(12), e99-e99.
Join our insider list for the latest research insights, product releases, and special offers—delivered straight to your inbox.